Human monocytes but not dendritic cells are killed by blocking of autocrine cyclooxygenase activity

Cellular Immunology

Volumn 258, Issue 1, 2009, Pages 107-114

  Oliveira, Bruno L ^a   Cavalcanti, Clara M ^a   Azevedo, Ana Paula S ^a   Tomiyoshi, Márcio Y ^a   Bergami Santos, Patrícia C ^a   Barbuto, José Alexandre M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti inflammatory drugs; Cell differentiation; Dendritic cells; Indomethacin; Monocytes; Prostaglandins

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANTIGEN PRESENTING CELL; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL KILLING; CELL VIABILITY; DENDRITIC CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; MONOCYTE; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CYCLOOXYGENASE INHIBITORS; DENDRITIC CELLS; HUMANS; INDOMETHACIN; MONOCYTES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67349083650     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.03.019     Document Type: Article

References (35)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9 (1991) 271-296
3. Hart D.N. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90 (1997) 3245-3287
4. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12 (1994) 991-1045
5. Takeuchi S., and Furue M. Dendritic cells: ontogeny. Allergol. Int. 56 (2007) 215-223
6. Zou G.M., and Tam Y.K. Cytokines in the generation and maturation of dendritic cells: recent advances. Eur. Cytokine Netw. 13 (2002) 186-199
7. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
8. Morelli A.E., and Thomson A.W. Dendritic cells under the spell of prostaglandins. Trends Immunol. 24 (2003) 108-111
9. Del P.A., Shao W.H., Mitola S., Santoro G., Sozzani S., and Haribabu B. Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. Blood 109 (2007) 626-631
10. Konturek S.J., and Pawlik W. Physiology and pharmacology of prostaglandins. Dig. Dis. Sci. 31 (1986) 6S-19S
11. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23 (2002) 144-150
12. Nencioni A., Grunebach F., Zobywlaski A., Denzlinger C., Brugger W., and Brossart P. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. J. Immunol. 169 (2002) 1228-1235
13. Lawrence T., Willoughby D.A., and Gilroy D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2 (2002) 787-795
14. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., and Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5 (1999) 698-701
15. Zhou W., Hashimoto K., Goleniewska K., O'Neal J.F., Ji S., Blackwell T.S., Fitzgerald G.A., Egan K.M., Geraci M.W., and Peebles Jr. R.S. Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells. J. Immunol. 178 (2007) 702-710
16. Folco G., and Murphy R.C. Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses. Pharmacol. Rev. 58 (2006) 375-388
17. Gualde N., and Harizi H. Prostanoids and their receptors that modulate dendritic cell-mediated immunity. Immunol. Cell Biol. 82 (2004) 353-360
18. Hartel C., von P.J., Gallner F., Strunk T., and Schultz C. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition. Scand. J. Immunol. 60 (2004) 412-420
19. Barbuto J.A., Ensina L.F., Neves A.R., Bergami-Santos P., Leite K.R., Marques R., Costa F., Martins S.C., Camara-Lopes L.H., and Buzaid A.C. Dendritic cell-tumor cell hybrid vaccination for metastatic cancer. Cancer Immunol. Immunother. 53 (2004) 1111-1118
20. Vermes I., Haanen C., Steffens-Nakken H., and Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184 (1995) 39-51
21. Ribeiro-Dias F., Marzagao Barbuto J.A., Tsujita M., and Jancar S. Discrimination between NK and LAK cytotoxic activities of murine spleen cells by MTT assay: differential inhibition by PGE(2) and EDTA. J. Immunol. Methods 241 (2000) 121-129
22. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal M.R., and Liu Y.J. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283 (1999) 1183-1186
23. Tacke F., and Randolph G.J. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211 (2006) 609-618
24. Lee J.J., Takei M., Hori S., Inoue Y., Harada Y., Tanosaki R., Kanda Y., Kami M., Makimoto A., Mineishi S., Kawai H., Shimosaka A., Heike Y., Ikarashi Y., Wakasugi H., Takaue Y., Hwang T.J., Kim H.J., and Kakizoe T. The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression?. Stem Cells 20 (2002) 448-459
25. Gosset P., Bureau F., Angeli V., Pichavant M., Faveeuw C., Tonnel A.B., and Trottein F. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J. Immunol. 170 (2003) 4943-4952
26. Leslie C.A., and Dubey D.P. Increased PGE2 from human monocytes isolated in the luteal phase of the menstrual cycle. Implications for immunity?. Prostaglandins 47 (1994) 41-54
27. Helleberg L. Clinical pharmacokinetics of indomethacin. Clin. Pharmacokinet. 6 (1981) 245-258
28. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231 (1971) 232-235
29. Fujii Y., Matsura T., Kai M., Matsui H., Kawasaki H., and Yamada K. Mitochondrial cytochrome c release and caspase-3-like protease activation during indomethacin-induced apoptosis in rat gastric mucosal cells. Proc. Soc. Exp. Biol. Med. 224 (2000) 102-108
30. Kim W.H., Yeo M., Kim M.S., Chun S.B., Shin E.C., Park J.H., and Park I.S. Role of caspase-3 in apoptosis of colon cancer cells induced by nonsteroidal anti-inflammatory drugs. Int. J. Colorectal Dis. 15 (2000) 105-111
31. Sanchez-Alcazar J.A., Bradbury D.A., Pang L., and Knox A.J. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways. Lung Cancer 40 (2003) 33-44
32. Ou Y.C., Yang C.R., Cheng C.L., Raung S.L., Hung Y.Y., and Chen C.J. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Eur. J. Pharmacol. 563 (2007) 49-60
33. de Groot D.J., Timmer T., Spierings D.C., Le T.K., de J.S., and de Vries E.G. Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells. Br. J. Cancer 92 (2005) 1459-1466
34. O'Doherty U., Peng M., Gezelter S., Swiggard W.J., Betjes M., Bhardwaj N., and Steinman R.M. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82 (1994) 487-493
35. Ito T., Inaba M., Inaba K., Toki J., Sogo S., Iguchi T., Adachi Y., Yamaguchi K., Amakawa R., Valladeau J., Saeland S., Fukuhara S., and Ikehara S. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J. Immunol. 163 (1999) 1409-1419